I am nto arguin with you but want to make a few points...

If the Medtone inhaler was such a big issue why are there 133 people on it on the current trials. If it was unsafe or if there is a problem 133 type 1 diabetics just went on it for 6 months. In my opinion Medtone would of been approved! On the current trials the medtone needs to be cleaned as well. So how come it was unsafe for whatever reason but safe for 133 patients to be on it now. Makes no sense and the FDA makes no sense.

On a side note:

I ran across this article here which shows how even insulin pumps cannot prevent the damage of the spikes after meals.

http://www.mevsdiabetes.com/managing-type-1-diabetes/

Afrezza solves this issue. Honestly in the future all type 1 diabetics should be on a basal inulin pump and take afrezza for meals. Type 2 afrezza during meals.